VacPertagen
- Prescription status not stated
- Antibiotics, antivirals and antifungals taken into the body
- Active substance
- Pertussis vaccine (recombinant, acellular, component, adsorbed)
- Made by
- BioNet Europe
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- VacPertagen is indicated for: - booster immunisation against pertussis of individuals 12 years of age and older,- passive protection against pertussis in early infancy following maternal immunisation during pregnancy.
From the official label · 2026-09-30 · European Medicines Agency
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
NetherlandsNo exact match for this strength and form
Details
| Made by | BioNet Europe |
|---|---|
| Active substance | Pertussis vaccine (recombinant, acellular, component, adsorbed) |
| Used in | Antibiotics, antivirals and antifungals taken into the body |
| Classification | J07AJ02 · Antibiotics, antivirals and antifungals taken into the body |
| Authorised on | 2026-01-09 |
| Last updated by the regulator | 2026-03-05 |
| EMA product number | EMEA/H/C/006304 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).